MinorDigestives. Multienzyme preparations×Combined supplement: fat-soluble vitamins D3 and K2
Updated · Methodology
Mechanism
Pancreatin acts only in the gut lumen: the enzymes are not absorbed intact but are digested like other proteins to peptides and amino acids (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). No interaction studies have been performed with pancreatin (Kreon SmPC, AEMPS, section 4.5). There is no medicinal product combining vitamins D3 and K2 in Spain, so the information on vitamin D3 comes from the colecalciferol SmPC. Colecalciferol is absorbed in the gut with the help of bile salts, better with food. It is converted in the liver and kidneys to active calcitriol and excreted mainly in bile and faeces (Colecalciferol Normon SmPC, AEMPS, sections 4.2 and 5.2). Antiepileptics, barbiturates and possibly other liver enzyme inducers reduce its effect, as do glucocorticoids. Colestyramine, colestipol, orlistat and liquid paraffin reduce its absorption. Thiazide diuretics retain calcium, and with cardiac glycosides the risk of arrhythmia rises (Colecalciferol Normon SmPC, AEMPS, section 4.5). There is no medicinal product containing vitamin K2 (menaquinone-7). According to the NIH Office of Dietary Supplements vitamin K fact sheet, vitamin K interacts with warfarin and other anticoagulants, and antibiotics, bile acid sequestrants and orlistat can affect vitamin K levels. Vitamin D3 is absorbed together with fat with the help of bile salts, and people with malabsorption may need higher doses (Colecalciferol Normon SmPC, AEMPS, sections 4.2 and 5.2). According to the NIH Office of Dietary Supplements vitamin D fact sheet, people with conditions that limit fat absorption are more likely to have inadequate vitamin D status. Pancreatin is used precisely for exocrine pancreatic insufficiency, to digest food (Kreon SmPC, AEMPS, section 4.1). The pancreatin and colecalciferol SmPCs say nothing about either product changing the absorption of the other.
Symptoms
No symptoms caused by this combination have been described. Fibrosing colonopathy has been reported in people with cystic fibrosis taking high doses of pancreatin, and anaphylactic reactions are rare. Chewing the capsules or holding them in the mouth can irritate the oral mucosa (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Excess vitamin D raises calcium in the blood and urine, causing nausea, vomiting, thirst, constipation, polyuria and dehydration. Chronic overdose can cause vascular and organ calcification (Colecalciferol Normon SmPC, AEMPS, section 4.9). Vitamin K has low toxicity, and no tolerable upper intake level has been set (NIH Office of Dietary Supplements, vitamin K fact sheet).
Management
The combination can be used, no dose change is needed, and no harmful interaction is known. According to their SmPCs, both products are taken with meals (Kreon and Colecalciferol Normon SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.2). In malabsorption, the vitamin D3 dose is adjusted to blood 25-hydroxycolecalciferol levels (Colecalciferol Normon SmPC, AEMPS, section 4.2). Pancreatin capsules should not be chewed or held in the mouth. Unusual or changing abdominal symptoms are assessed to rule out fibrosing colonopathy, especially in people with cystic fibrosis taking more than 10 000 lipase units per kilogram per day (Kreon SmPC, AEMPS, section 4.4). When vitamin D3 is taken long term at more than 1000 IU a day, serum calcium is monitored. Colecalciferol is not used in hypercalcaemia, hypercalciuria, kidney stones or severe renal impairment (Colecalciferol Normon SmPC, AEMPS, sections 4.3 and 4.4).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- NIH Office of Dietary Supplements: Vitamin K – Health Professional Fact Sheet (2025)– NIH ODS, Vitamin K, Warfarin and similar anticoagulants
- AEMPS: Ficha técnica: Pancreatina, Kreon 35.000 U (nº registro 83862), sección 4.5 (2026)– AEMPS, CIMA, nº registro 83862 (Kreon 35.000 U cápsulas duras gastrorresistentes, Viatris), revisión 09/2026, secciones 4.4, 4.5 y 5.2
- AEMPS: Ficha técnica: Colecalciferol, Colecalciferol Normon 10.000 UI/ml gotas orales (nº registro 89368), sección 4.5 (2024)– AEMPS, CIMA, nº registro 89368 (Colecalciferol Normon 10.000 UI/ml gotas orales en solución, Laboratorios Normon), revisión 02/2024, secciones 4.2, 4.3, 4.4, 4.5, 4.9 y 5.2
- NIH Office of Dietary Supplements: Vitamin D – Health Professional Fact Sheet (2025)– NIH Office of Dietary Supplements, Vitamin D – Fact Sheet for Health Professionals, updated 27.06.2025 (Groups at Risk of Vitamin D Inadequacy; Interactions with Medications)